Cellular origin of ionizing radiation-induced NF-κB activation in vivo and role of NF-κB in ionizing radiation-induced lymphocyte apoptosis

International Journal of Radiation Biology

Volumn 79, Issue 11, 2003, Pages 849-861

  Meng, A ^a   Yu, T ^b   Chen, G ^b   Brown, S A ^b,c   Wang, Y ^a   Thompson, J S ^b,c   Zhou, D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIHEXYLOXACARBOCYANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; OLIGONUCLEOTIDE; RAG1 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL ISOLATION; CONTROLLED STUDY; IONIZING RADIATION; KNOCKOUT GENE; MACROPHAGE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIATION EXPOSURE; STAINING; T LYMPHOCYTE;

ANIMALS; ANNEXIN A5; APOPTOSIS; B-LYMPHOCYTES; CARBOCYANINES; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUORESCENT DYES; G0 PHASE; G1 PHASE; GENES, RAG-1; IN SITU NICK-END LABELING; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; OLIGONUCLEOTIDES; RADIATION, IONIZING; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 0346057817     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000310001622814     Document Type: Article

References (57)

1. AGGARWAL, B. B., 2000. Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. Biochemical Pharmacology, 60, 1033-1039.
2. ANDREWS, N. C. and FALLER, D. V., 1991, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research, 19, 2499.
3. BAEUERLE, P. A. and HENKEL, T., 1994, Function and activation of NF-kappa B in the immune system. Annual Review of Immunology, 12, 141-179.
4. BAICHWAL, V. R. and BAEUERLE, P. A., 1997, Activate NF-kappa B or die. Current Biology, 7, R94-R96.
5. BALDWIN, A. S., JR. 1996, The NF-kappa B and 1 kappa B proteins: new discoveries and insights. Annual Review of Immunology, 14, 649-683.
6. BALDWIN, A. S., 2001, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. Journal of Clinical Investigation, 107, 241-246.
7. BARKETT, M. and GILMORE, T. D., 1999, Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogenic, 18, 6910-6924.
8. BOOTHBY, M. R., MORA, A. L., SCHERER, D. C., BROCKMAN, J. A. and BALLARD, D. W., 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. Journal of Experimental Medicine, 185, 1897-1907.
9. BOURS, V., BENTIRES-ALJ, M., HELLIN, A. C., VIATOUR, P., ROBE, P., DELHALLE, S., BENOIT, V. and MERVILLE, M. P., 2000, Nuclear factor-kappa B, cancer, and apoptosis. Biochemical Pharmacology, 60, 1085-1089.
10. CHAN, H., BARTOS, D. P. and OWEN-SCHAUB, L. B., 1999, Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Molecular and Cellular Biology, 19, 2098-2108.
11. CLARKE, A. R., PURDIE, C. A., HARRISON, D. J., MORRIS, R. G., BIRD, C. C., HOOPER, M. L. and WYLLIE, A. H., 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
12. DARZYNKIEWICZ, Z. and BEDNER, E., 2000, Analysis of apoptotic cells by flow and laser scanning cytometry. Methods in Enzymology, 322, 18-39.
13. DUDLEY, E., HORNUNG, F., ZHENG, L., SCHERER, D., BALLARD, D. and LENARDO, M., 1999, NF-kappaB regulates Fas/APO-1/. European Journal of Immunology, 29, 878-886.
14. FERREIRA, V., SIDENIUS, N., TARANTINO, N., HUBERT, P., CHATENOUD, L., BLASI, F. and KORNER, M., 1999, In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. Journal of Immunology, 162, 6442-6450.
15. GHOSH, S., MAY, M. J. and KOPP, E. B., 1998, NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology, 16, 225-260.
16. GRUMONT, R. J., ROURKE, I. J., O'REILLY, L. A., STRASSER, A., MIYAKE, K., SHA, W. and GERONDAKIS, S., 1998, B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. Journal of Experimental Medicine, 187, 663-674.
17. HALLAHAN, D., CLARK, E. T., KUCHIBHOTLA, J., GEWERTZ, B. L. and COLLINS, T., 1995, E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochemical and Biophysical Research Communications, 217, 784-795.
18. HETTMANN, T., DIDONATO, J., KARIN, M. and LEIDEN, J. M., 1999, An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. Journal of Experimental Medicine, 189, 145-158.
19. HSU, S. C., GAVRILIN, M. A., LEE, H. H., WU, C. C., HAN, S. H. and LAI, M. Z., 1999, NF-kappa B-dependent Fas ligand expression. European Journal of Immunology, 29, 2948-2956.
20. IKEDA, A., SUN, X., LI, Y., ZHANG, Y., ECKNER, R., DOI, T. S., TAKAHASHI, T., OBATA, Y., YOSHIOKA, K. and YAMAMOTO, K., 2000, p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. Biochemical and Biophysical Research Communications, 272, 375-379.
21. JUNG, M. and DRITSCHILO, A., 2001, NF-kappa B signaling pathway as a target for human tumor radiosensitization. Seminars in Radiation Oncology, 11, 346-351.
22. KASIBHATLA, S., BRUNNER, T., GENESTIER, L., ECHEVERRI, F., MAHBOUBI, A. and GREEN, D. R., 1998, DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Molecular Cell, 1, 543-551.
23. KASIBHATLA, S., GENESTIER, L. and GREEN, D. R., 1999, Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. Journal of Biological Chemistry, 274, 987-992.
24. KHALED, A. R., BUTFILOSKI, E. J., SOBEL, E. S. and SCHIFFENBAUER, J., 1998, Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function. Clinical Immunology and Immunopathology, 86, 170-179.
25. KHOSHNAN, A., TINDELL, C., LAUX, I., BAE, D., BENNETT, B. and NEL, A. E., 2000, The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. Journal of Immunology, 165, 1743-1754.
26. KOLENKO, V., BLOOM, T., RAYMAN, P., BUKOWSKI, R., HSI, E. and FINKE, J., 1999, Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. Journal of Immunology, 163, 590-598.
27. LEE, H. H., DADGOSTAR, H., CHENG, Q., SHU, J. and CHENG, G., 1999, NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proceedings of the National Academy of Sciences, USA, 96, 9136-9141.
28. LEE, J. M. and BERNSTEIN, A., 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742-5746.
29. LEE, S. J., DIMTCHEV, A., LAVIN, M. F., DRITSCHILO, A. and JUNG, M., 1998, A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene, 17, 1821-1826.
30. LIN, B., WILLIAMS-SKIPP, C., TAO, Y., SCHLEICHER, M. S., CANO, L. L., DUKE, R. C. and SCHEINMAN, R. I., 1999, NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death and Differentiation, 6, 570-582.
31. LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
32. MACFARLANE, M., JONES, N. A., DIVE, C. and COHEN, G. M., 1996, DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes. Molecular Pharmacology, 50, 900-911.
33. MAJNO, G. and JORIS, I., 1995, Apoptosis, oncosis, and necrosis. An overview of cell death. American Journal of Pathology, 146, 3-15.
34. MALCOMSON, R. D., CLARKE, A. R., PETER, A., COUTTS, S. B., HOWIE, S. E. and HARRISON, D. J., 1997, Apoptosis induced by gamma-irradiation, but not CD4 ligation, of peripheral T lymphocytes in vivo is p53-dependent. Journal of Pathology, 181, 166-171.
35. MATSUI, K., FINE, A., ZHU, B., MARSHAK-ROTHSTEIN, A. and JU, S. T., 1998, Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T-cell hybridoma. Journal of Immunology, 161, 3469-3473.
36. MAYO, M. W. and BALDWIN, A. S., 2000, The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochimica et Biophysica Acta, 1470, M55-M62.
37. MOHAN, N. and MELTZ, M. L., 1994, Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiation Research, 140, 97-104.
38. MOMBAERTS, P., IACOMINI, J., JOHNSON, R. S., HERRUP, K., TONEGAWA, S. and PAPAIOANNOU, V. E., 1992, RAG-1-deficient mice have no mature B and T lymphocytes. Cell, 68, 869-877.
39. MORISHITA, R., SUGIMOTO, T., AOKI, M., KIDA, I., TOMITA, N., MORIGUCHI, A., MAEDA, K., SAWA, Y., KANEDA, Y., HIGAKI, J. and OGIHARA, T., 1997, In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nature Medicine, 3, 894-899.
40. PERKINS, N. D., 2000, The Rel/NF-kappa B family: friend and foe. Trends in Biochemical Sciences, 25, 434-440.
41. PRASAD, A. V., MOHAN, N., CHANDRASEKAR, B. and MELTZ, M. L., 1994, Activation of nuclear factor kappa B in human lymphoblastoid cells by low-dose ionizing radiation. Radiation Research, 138, 367-372.
42. RAJU, U., GUMIN, G. J., NOEL, F. and TOFILON, P. J., 1998, IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells. International Journal of Radiation Biology, 74, 617-624.
43. RAVI, R., MOOKERJEE, B., VAN HENSBERGEN, Y., BEDI, G. C., GIORDANO, A., EL DEIRY, W. S., FUCHS, E. J. and BEDI, A., 1998, p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Research, 58, 4531-4536.
44. RIVERA-WALSH, I., GVIJIC, M. E., XIAO, G. and SUN, S. C., 2000, The NF-kappa B signaling pathway is not required for Fas ligand gene induction but mediates protection from activation-induced cell death. Journal of Biological Chemistry, 275, 25222-25230.
45. SCHWARTZ, S. A., HERNANDEZ, A. and MARK, E. B., 1999, The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies. Surgical Oncology, 8, 143-153.
46. SHARMA, H. W., PEREZ, J. R., HIGGINS-SOCHASKI, K., HSIAO, R. and NARAYANAN, R., 1996, Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis. Anticancer Research, 16, 61-69.
47. UCKUN, F. M., SCHIEVEN, G. L., TUEL-AHLGREN, L. M., DIBIRDIK, I., MYERS, D. E., LEDBETTER, J. A. and SONG, C. W., 1993, Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proceedings of the National Academy of Sciences, USA, 90, 252-256.
48. VALERIE, K., LASTER, W. S., KIRKHAM, J. C. and KUEMMERLE, N. B., 1995, Ionizing radiation activates nuclear factor kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry, 34, 15768-15776.
49. VOS, I. H., GOVERS, R., CRONE, H. J., KLEIJ, L., SCHURINK, M., DE WEGER, R. A., GOLDSCHMEDING, R. and RABELINK, T. J., 2000, NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB Journal, 14, 815-822.
50. WADDICK, K. G. and UCKUN, F. M., 1999, Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target. Biochemical Pharmacology, 57, 9-17.
51. WANG, C. Y., CUSACK, J. C., JR, LIU, R. and BALDWIN, A. S., JR, 1999, Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nature Medicine, 5, 412-417.
52. WEBSTER, G. A. and PERKINS, N. D., 1999, Transcriptional cross talk between NF-kappaB and pD3. Molecular and Cellular Biology, 19, 3485-3495.
53. WEICHSELBAUM, R. R., HALLAHAN, D., FUKS, Z. and KUFE, D., 1994, Radiation induction of immediate early genes: effectors of the radiation-stress response. International Journal of Radiation Oncology, Biology, Physics, 30, 229-234.
54. WILSON, R. E., TAYLOR, S. L., ATHERTON, G. T., JOHNSTON, D., WATERS, C. M. and NORTON, J. D., 1993, Early response gene signalling cascades activated by ionising radiation in primary human B-cells. Oncogene, 8, 3229-3237.
55. YANG, C. R., WILSON-VAN PATTEN, C., PLANCHON, S. M., WUERZBERGER-DAVIS, S. M., DAVIS, T. W., CUTHILL, S., MIYAMOTO, S. and BOOTHMAN, D. A., 2000, Coordinate modulation of Spl, NF-kappa B, and p53 in confluent human malignant melanoma cells aflcr ionizing radiation. FASEB Journal, 14, 379-390.
56. ZHOU, D., BROWN, S. A., YU, T., CHEN, G., BARVE, S., KANG, B. C. and THOMPSON, J. S., 1999, A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo. Radiation Research, 151, 703-709.
57. ZHOU, D., YU, T., CHEN, G., BROWN, S. A., YU, Z., MATTSON, M. P. and THOMPSON, J. S., 2001, Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo. International Journal of Radiation Biology, 77, 763-772.